Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

XX4 Pharmaceuticals, Inc

EconomyAI buildoutMarket MapFundsWatchlist
Log in
X

X4 Pharmaceuticals, Inc

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $2.4M. Net result −$16.16M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $2.4M. Running result $2.4M. Revenue: $2.4M.
  • Cost of revenue: −$1.62M. Running result $783K.
  • Gross profit: $783K. Running result $783K.
  • Operating costs: −$17.17M. Running result −$16.39M.
  • Operating income: −$16.39M. Running result −$16.39M.
  • Other income: $236K. Running result −$16.16M.
  • Pre-tax loss: −$16.16M. Running result −$16.16M.
  • Income tax expense: −$2K. Running result −$16.16M.
  • Net loss: −$16.16M. Running result −$16.16M.